Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU RAIZET : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU RAIZET is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LES ABYMES (97139), this company of category PME shows in 2024 a net income positive of 257 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU RAIZET (SIREN 920152568)
Indicator 2024 2023
Revenue N/C N/C
Net income 256 863 € 65 683 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DU RAIZET generates positive net income of 257 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 66 k€ -> 257 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

256 863 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1552%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1552.079%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

5.402%

Solvency indicators evolution
SELARL PHARMACIE DU RAIZET

Sector positioning

Debt ratio
1552.08 2024
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELARL PHARMACIE DU RAIZET (1552.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
5.4% 2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELARL PHARMACIE DU RAIZET (5.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of SELARL PHARMACIE DU RAIZET in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DU RAIZET is estimated at 3 585 997 € (range 2 497 231€ - 5 364 857€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2497k€ 3585k€ 5364k€
3 585 997 € Range: 2 497 231€ - 5 364 857€
NAF 5 année 2024

Valuation method used

Net Income Multiple
256 863 € × 14.0x = 3 585 997 €
Range: 2 497 232€ - 5 364 857€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU RAIZET with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU RAIZET

What is the revenue of SELARL PHARMACIE DU RAIZET ?

The revenue of SELARL PHARMACIE DU RAIZET is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU RAIZET profitable?

Yes, SELARL PHARMACIE DU RAIZET generated a net profit of 257 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DU RAIZET ?

The headquarters of SELARL PHARMACIE DU RAIZET is located in LES ABYMES (97139), in the department Guadeloupe.

Where to find the tax return of SELARL PHARMACIE DU RAIZET ?

The tax return of SELARL PHARMACIE DU RAIZET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU RAIZET operate?

SELARL PHARMACIE DU RAIZET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.